MCOLN1 and ovarian cancer: Therefore, further studies are warranted to elucidate the more specific molecular mechanisms that underlie the link between TRPML1 inhibition and arginine deprivation, potentially providing valuable insights for the development of targeted therapies in overcoming chemoresistance in ovarian cancer.